Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells. [electronic resource]
Producer: 20000912Description: 3675-83 p. digitalISSN:- 0950-9232
- Animals
- CDC2-CDC28 Kinases
- Cell Cycle -- drug effects
- Cell Cycle Proteins
- Cyclin-Dependent Kinase 2
- Cyclin-Dependent Kinase Inhibitor p27
- Cyclin-Dependent Kinases -- antagonists & inhibitors
- Cytokines -- metabolism
- DNA -- biosynthesis
- DNA-Binding Proteins -- metabolism
- Growth Inhibitors -- metabolism
- Humans
- Interleukin-10 -- genetics
- Interleukin-6 -- metabolism
- Leukemia Inhibitory Factor
- Lymphokines -- metabolism
- Microtubule-Associated Proteins -- metabolism
- Milk Proteins
- Mitogen-Activated Protein Kinases -- metabolism
- Oncostatin M
- Peptides -- metabolism
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Rats
- Receptors, Interleukin -- genetics
- Receptors, Interleukin-10
- STAT3 Transcription Factor
- STAT5 Transcription Factor
- Trans-Activators -- metabolism
- Tumor Cells, Cultured
- Tumor Suppressor Proteins
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.